The assessment of total cardiovascular risk in hypertensive subjects in primary care

References

• Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL; Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347–60.
   PubMed Web of Science ®Google Scholar
• Danaei G, Lawes CMM, Vander Hoorn S, Murray CJL, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than- optimum blood glucose concentration: comparative risk assessment. Lancet. 2006;368:1651–9.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Alderman MH. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation. 1993;88: 1444–5.
   PubMed Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, ; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–87.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, ; the National High Blood Pressure Education Program Coordinating Committee. The Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–52.
   Google Scholar
• Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertension. 2003;21:1983–92.
   PubMed Web of Science ®Google Scholar
• Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Bacquer G, ; on behalf of the SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987–1003.
   PubMed Web of Science ®Google Scholar
• D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, . General cardiovascular risk profile for use in primary care. The Framingham Heart Study. Circulation. 2008;117:743–53.
   PubMed Web of Science ®Google Scholar
• Korhonen P, Aarnio P, Saaresranta T, Jaatinen P, Kantola I. Glucose homeostasis in hypertensive subjects. Hypertension. 2008;51:945–9.
   PubMed Web of Science ®Google Scholar
• Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, .; on behalf of the ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second Consensus Conference on Home Blood Pressure Monitoring. J Hypertens. 2008;26:1505–10.
   PubMed Web of Science ®Google Scholar
• Sokolow M, Lyon T. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;37:161–86.
   PubMed Web of Science ®Google Scholar
• Molloy TJ, Okin PM, Devereux RB, Kligfield P. Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. J Am Coll Cardiol. 1992;20:1180–6.
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek J. Expressing the MDRD study equation for estimating GFR with IDMS traceable (gold standard) serum creatinine values. J Am Soc Nephrol. 2005;16:69A.
   Google Scholar
• World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF consultation. Geneva: World Health Organization; 2006.
   Google Scholar
• Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, . Markers of inflammation and cardiovascular disease. Application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511.
   PubMed Web of Science ®Google Scholar
• DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating curves: A nonparametric approach. Biometrics. 1988;44:837–45.
   PubMed Web of Science ®Google Scholar
• ; Ankle Brachial Index CollaborationFowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, . Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality. A meta-analysis. JAMA. 2008;300:197–208.
   PubMed Web of Science ®Google Scholar
• Lamina C, Meisinger C, Heid IM, Löwel H, Rantner B, Koenig W, .; for the KORA Study Group. Association of ankle-brachial index and plaques in the carotid and femoral arteries with cardiovascular events and total mortality in a population-based study with 13 years of follow-up. Eur Heart J. 2006;27:2580–7.
   PubMed Web of Science ®Google Scholar
• Diehm C, Lange S, Darius H, Pittrow D, von Stritzky B, Tepohl G, .; for the getABI Study Group. Association of low ankle brachial index with high mortality in primary care. Eur Heart J. 2006;27:1743–9.
   PubMed Web of Science ®Google Scholar
• Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR; on behalf of the TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33:S1–75.
   PubMed Web of Science ®Google Scholar
• Espinola-Klein C, Rupprecht HJ, Bickel C, Lackner K, Savvidis S, Messow CM, .; for the Atherogene Investigators. Different calculations of ankle brachial index and their impact on cardiovascular risk prediction. Circulation. 2008;118:961–7.
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, . Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension. 2003;42:1050–65.
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.
   PubMed Web of Science ®Google Scholar
• Levy D, Salomon M, D’Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation. 1994;90:1786–93.
   PubMed Web of Science ®Google Scholar
• Antikainen RL, Grodzicki T, Beevers DG, Webster J, Jokelainen JJ, Bulpitt CJ. Left ventricular hypertrophy by Sokolow-Lyon voltage criterion predicts mortality in overweight hypertensive subjects. J Hum Hypertens. 2009; 23:20–6.
   PubMed Web of Science ®Google Scholar
• Estes EH, Jackson KP. The electrocardiogram in left ventricular hypertrophy: past and future. J Electrocardiol. 2009;42:589–92.
   PubMed Web of Science ®Google Scholar
• Cook NR, Buring JE, Ridker PM. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med. 2006;145:21–9.
   PubMed Web of Science ®Google Scholar
• ; Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical PracticeGraham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, . European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J. 2007;28: 2375–414.
   PubMed Web of Science ®Google Scholar
• Smith SC, Jackson R, Pearson TA, Fuster V, Yusuf S, Faergeman O, . Principles for national and regional guidelines on cardiovascular disease prevention. A scientific statement from the World Heart and Stroke Forum. Circulation. 2004;109:3112–21.
   PubMed Web of Science ®Google Scholar
• Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P. Cardiovascular risk factor changes in Finland 1972–1997. Int J Epidemiol. 2000;29:49–56.
   PubMed Web of Science ®Google Scholar
• Lengelé J-P, Vinck WJ, De Plaen J-F, Persu A. Cardiovascular risk assessment in hypertensive patients: major discrepancy according to ESH and SCORE strategies. J Hypertens. 2007;25:757–62.
   Google Scholar